Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $357.63 million. The enterprise value is $318.42 million.
| Market Cap | 357.63M |
| Enterprise Value | 318.42M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 60.11 million shares outstanding. The number of shares has increased by 56.50% in one year.
| Current Share Class | 60.11M |
| Shares Outstanding | 60.11M |
| Shares Change (YoY) | +56.50% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 4.11% |
| Owned by Institutions (%) | 26.88% |
| Float | 32.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.18 |
| Forward PS | 835.71 |
| PB Ratio | 18.51 |
| P/TBV Ratio | 18.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.26, with a Debt / Equity ratio of 2.41.
| Current Ratio | 8.26 |
| Quick Ratio | 8.17 |
| Debt / Equity | 2.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.56 |
Financial Efficiency
Return on equity (ROE) is -397.30% and return on invested capital (ROIC) is -62.05%.
| Return on Equity (ROE) | -397.30% |
| Return on Assets (ROA) | -45.73% |
| Return on Invested Capital (ROIC) | -62.05% |
| Return on Capital Employed (ROCE) | -56.73% |
| Weighted Average Cost of Capital (WACC) | 6.93% |
| Revenue Per Employee | $371,814 |
| Profits Per Employee | -$692,698 |
| Employee Count | 86 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 0.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +105.17% in the last 52 weeks. The beta is 0.52, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +105.17% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 4.44 |
| Relative Strength Index (RSI) | 54.60 |
| Average Volume (20 Days) | 335,065 |
Short Selling Information
The latest short interest is 2.37 million, so 3.95% of the outstanding shares have been sold short.
| Short Interest | 2.37M |
| Short Previous Month | 2.46M |
| Short % of Shares Out | 3.95% |
| Short % of Float | 7.20% |
| Short Ratio (days to cover) | 5.97 |
Income Statement
In the last 12 months, OBIO had revenue of $31.98 million and -$59.57 million in losses. Loss per share was -$1.00.
| Revenue | 31.98M |
| Gross Profit | 31.82M |
| Operating Income | -57.99M |
| Pretax Income | -59.03M |
| Net Income | -59.57M |
| EBITDA | -57.64M |
| EBIT | -57.99M |
| Loss Per Share | -$1.00 |
Balance Sheet
The company has $109.96 million in cash and $70.76 million in debt, with a net cash position of $39.20 million or $0.65 per share.
| Cash & Cash Equivalents | 109.96M |
| Total Debt | 70.76M |
| Net Cash | 39.20M |
| Net Cash Per Share | $0.65 |
| Equity (Book Value) | 29.42M |
| Book Value Per Share | 0.32 |
| Working Capital | 97.77M |
Cash Flow
In the last 12 months, operating cash flow was -$58.32 million and capital expenditures -$781,000, giving a free cash flow of -$59.10 million.
| Operating Cash Flow | -58.32M |
| Capital Expenditures | -781,000 |
| Depreciation & Amortization | 349,000 |
| Net Borrowing | 55.00M |
| Free Cash Flow | -59.10M |
| FCF Per Share | -$0.98 |
Margins
Gross margin is 99.51%, with operating and profit margins of -181.36% and -184.60%.
| Gross Margin | 99.51% |
| Operating Margin | -181.36% |
| Pretax Margin | -184.60% |
| Profit Margin | -184.60% |
| EBITDA Margin | -180.27% |
| EBIT Margin | -181.36% |
| FCF Margin | n/a |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -56.50% |
| Shareholder Yield | -56.50% |
| Earnings Yield | -16.66% |
| FCF Yield | -16.53% |
Analyst Forecast
The average price target for OBIO is $12.43, which is 108.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.43 |
| Price Target Difference | 108.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -25.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -3.83 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.83 |
| Piotroski F-Score | 4 |